{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":3,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":3,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"f7ce5b11d599","filters":{"venue":"Australasian biotechnology"}},"results":[{"id":"W2906279666","doi":"","title":"Medicinal marijuana: Commercialisation and innovation in a complex regulatory environment","year":2018,"lang":"en","type":"article","venue":"Australasian biotechnology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Legislation; Project commissioning; Competition (biology); Business; Face (sociological concept); State (computer science); Production (economics); Publishing; International trade; Industrial organization; Marketing; Economics; Political science; Law; Ecology","authors":[{"name":"Sally J. Davis","is_ca":false},{"name":"Alex Tzanidis","is_ca":false},{"name":"Darron Saltzman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01691066078453741,"gpt":0.2929339454938176,"spread":0.2760232847092802,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01244241,0.0002287231,0.0004368938,0.0009929409,0.002769506,0.01018833,0.00102222,0.002791249,0.004119627],"category_scores_gemma":[0.00867574,0.000366005,0.0005446764,0.0009285313,0.01160816,0.007377378,0.005988244,0.0038718,0.0008671184],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005391134,"about_ca_system_score_gemma":0.0107729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003774686,"about_ca_topic_score_gemma":0.005424622,"domain_scores_codex":[0.9925044,0.003053284,0.0002820471,0.0008601011,0.002520517,0.0007796985],"domain_scores_gemma":[0.9916882,0.003949742,0.001025644,0.0007876778,0.001374507,0.001174264],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001165637,0.0002559847,0.004228777,0.0004768016,0.00006532048,0.001137626,0.004853211,0.003497045,0.01535729,0.8370504,0.008751827,0.1242092],"study_design_scores_gemma":[0.000081137,0.0005225951,0.01439924,0.0009876773,0.00004745971,0.001003347,0.00785144,0.007147107,0.0064714,0.5998356,0.3615173,0.0001357777],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.3498668,0.01842262,0.07614565,0.1760723,0.0008631434,0.000740217,0.0002321004,0.0003647201,0.3772925],"genre_scores_gemma":[0.9413085,0.009997654,0.02168767,0.007063816,0.0003557603,0.0002343067,0.0000788767,0.00006112716,0.01921224],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.01244241,"threshold_uncertainty_score":0.06580251,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2285934247","doi":"","title":"International Financing Options Rise for Australian Biotechs: Selling Product Royalty Streams to Secure Non-dilutive Capital","year":2010,"lang":"en","type":"article","venue":"Australasian biotechnology","topic":"Private Equity and Venture Capital","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Finance; Capital (architecture); Business; Project commissioning; Product (mathematics); Publishing; Space (punctuation); Political science; Geography","authors":[{"name":"Todd C Davis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01182093812061561,"gpt":0.2480476190170579,"spread":0.2362266808964423,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004259218,0.0004092749,0.0002098459,0.002611576,0.002818342,0.008145127,0.000974325,0.00274301,0.03276907],"category_scores_gemma":[0.01109986,0.0003605921,0.0005461455,0.002544592,0.001213416,0.004823215,0.003275572,0.004020644,0.005126229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005036252,"about_ca_system_score_gemma":0.01013962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01420819,"about_ca_topic_score_gemma":0.01935831,"domain_scores_codex":[0.9972149,0.0003747819,0.00008157991,0.0001786042,0.001648481,0.000501615],"domain_scores_gemma":[0.9949926,0.0006729933,0.0005285501,0.0004604863,0.001657774,0.001687724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001905496,0.0001988171,0.008083863,0.0005484732,0.00002370752,0.0008541751,0.006220503,0.0007889645,0.007179765,0.29723,0.2100938,0.4685874],"study_design_scores_gemma":[0.00001908536,0.0001138973,0.01256037,0.0002089591,0.00001477552,0.0003909896,0.000573796,0.001150598,0.001479321,0.009638065,0.9738109,0.00003914639],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.09328513,0.00770002,0.01516124,0.05418379,0.001822576,0.000625353,0.0008922504,0.001333824,0.8249958],"genre_scores_gemma":[0.4385697,0.006899738,0.02388309,0.007032479,0.0008547095,0.0002419185,0.001089373,0.0003679107,0.5210611],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03276907,"threshold_uncertainty_score":0.1096234,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2756701234","doi":"","title":"Nexvet Biopharma - Seizing the opportunity in animal health","year":2013,"lang":"en","type":"article","venue":"Australasian biotechnology","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Project commissioning; Business; Socioeconomics; CATS; Agricultural economics; Pet therapy; Publishing; Demography; Veterinary medicine; Advertising; Demographic economics; Geography; Medicine; Economics; Animal welfare; Political science; Law; Biology; Sociology; Ecology; Internal medicine; Archaeology","authors":[{"name":"Mark Heffernan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06665569293818359,"gpt":0.3659671508792589,"spread":0.2993114579410753,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002523813,0.0003339601,0.0002806219,0.0008021191,0.0005161493,0.002074921,0.0004018411,0.001900933,0.02545518],"category_scores_gemma":[0.001071446,0.0001798988,0.0002694725,0.0004542254,0.0007360055,0.001602163,0.001526769,0.001943148,0.009859585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009981375,"about_ca_system_score_gemma":0.001612966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007179183,"about_ca_topic_score_gemma":0.002698264,"domain_scores_codex":[0.9992878,0.0001921191,0.00002858859,0.00007917524,0.0003239162,0.00008844126],"domain_scores_gemma":[0.9990233,0.0001594314,0.0001018063,0.0000489564,0.0002486311,0.0004177649],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006006191,0.0006804887,0.002777499,0.001062162,0.00003120281,0.0006575099,0.0003339634,0.0003506831,0.0598433,0.03462698,0.1992943,0.6997412],"study_design_scores_gemma":[0.00006000756,0.0004962215,0.002143702,0.0003930548,0.00001130827,0.0007330304,0.0001403877,0.0002929184,0.009587435,0.003712464,0.982419,0.00001056416],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.05976832,0.2940497,0.01240705,0.1038841,0.006673982,0.0003774226,0.00177285,0.001617331,0.5194492],"genre_scores_gemma":[0.2374179,0.1912076,0.0240672,0.02840968,0.003051248,0.0002940259,0.00305623,0.000271984,0.5122241],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.02545518,"threshold_uncertainty_score":0.08515602,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}